Prothena Corporation plc

NasdaqGS:PRTA Stok Raporu

Piyasa değeri: US$811.4m

Prothena Yönetim

Yönetim kriter kontrolleri 2/4

Prothena CEO'su Gene Kinney, Sep2016 tarihinde atandı, in görev süresi 8.17 yıldır. in toplam yıllık tazminatı $ 7.04M olup, şirket hissesi ve opsiyonları dahil olmak üzere 9% maaş ve 91% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.024% ine doğrudan sahiptir ve bu hisseler $ 192.88K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.7 yıl ve 5.1 yıldır.

Anahtar bilgiler

Gene Kinney

İcra Kurulu Başkanı

US$7.0m

Toplam tazminat

CEO maaş yüzdesi9.0%
CEO görev süresi8.2yrs
CEO sahipliği0.02%
Yönetim ortalama görev süresi7.7yrs
Yönetim Kurulu ortalama görev süresi5.1yrs

Son yönetim güncellemeleri

Recent updates

Prothena (NASDAQ:PRTA) Is In A Good Position To Deliver On Growth Plans

Nov 06
Prothena (NASDAQ:PRTA) Is In A Good Position To Deliver On Growth Plans

Prothena: Delays And Data Uncertainty Undermine Case For Investing (Downgrade)

Oct 18

Prothena Corporation plc (NASDAQ:PRTA) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Oct 02
Prothena Corporation plc (NASDAQ:PRTA) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Unpleasant Surprises Could Be In Store For Prothena Corporation plc's (NASDAQ:PRTA) Shares

Jul 26
Unpleasant Surprises Could Be In Store For Prothena Corporation plc's (NASDAQ:PRTA) Shares

Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

Jun 19
Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

Prothena: Potential For Future Price Drop On Failure Risk Of Late-Stage Trials

Jun 07

New Forecasts: Here's What Analysts Think The Future Holds For Prothena Corporation plc (NASDAQ:PRTA)

May 14
New Forecasts: Here's What Analysts Think The Future Holds For Prothena Corporation plc (NASDAQ:PRTA)

Prothena: Alzheimer's Data Update In 2024 Could Move The Needle

Feb 23

Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%

Feb 08
Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%

Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?

Dec 20
Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?

Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business

Nov 24
Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business

Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk

Oct 27
Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk

Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

Aug 25
Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today

May 10
What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today

We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth

Apr 23
We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth

Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook

Mar 01
Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook

We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate

Dec 28
We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate

Prothena: Paying A Premium To Cover All The Alzheimer's Bases

Sep 29

Prothena GAAP EPS of -$0.88 misses by $0.31

Aug 08

CEO Tazminat Analizi

Gene Kinney'un ücretlendirmesi Prothena'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$132m

Jun 30 2024n/an/a

-US$51m

Mar 31 2024n/an/a

-US$172m

Dec 31 2023US$7mUS$631k

-US$147m

Sep 30 2023n/an/a

-US$73m

Jun 30 2023n/an/a

-US$141m

Mar 31 2023n/an/a

-US$128m

Dec 31 2022US$7mUS$601k

-US$117m

Sep 30 2022n/an/a

-US$156m

Jun 30 2022n/an/a

-US$1m

Mar 31 2022n/an/a

US$67m

Dec 31 2021US$5mUS$573k

US$67m

Sep 30 2021n/an/a

US$69m

Jun 30 2021n/an/a

-US$70m

Mar 31 2021n/an/a

-US$124m

Dec 31 2020US$3mUS$554k

-US$111m

Sep 30 2020n/an/a

-US$102m

Jun 30 2020n/an/a

-US$91m

Mar 31 2020n/an/a

-US$80m

Dec 31 2019US$3mUS$538k

-US$78m

Sep 30 2019n/an/a

-US$79m

Jun 30 2019n/an/a

-US$84m

Mar 31 2019n/an/a

-US$128m

Dec 31 2018US$11mUS$525k

-US$156m

Sep 30 2018n/an/a

-US$181m

Jun 30 2018n/an/a

-US$209m

Mar 31 2018n/an/a

-US$167m

Dec 31 2017US$5mUS$521k

-US$153m

Tazminat ve Piyasa: Gene 'nin toplam tazminatı ($USD 7.04M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 3.18M ).

Tazminat ve Kazançlar: Gene şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Gene Kinney (55 yo)

8.2yrs

Görev süresi

US$7,043,826

Tazminat

Dr. Gene G. Kinney, Ph D., has been the Chief Executive Officer and President of Prothena Corporation plc since September 26, 2016 and October 3, 2016 respectively and served as its Chief Operating Officer...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Gene Kinney
President8.2yrsUS$7.04m0.024%
$ 192.9k
Tran Nguyen
CFO & Chief Strategy Officer11.7yrsUS$2.70m0.0060%
$ 48.3k
Brandon Smith
Chief Operating Officer3.1yrsUS$2.63m0%
$ 0
Carol Karp
Chief Regulatory Officer7.9yrsUS$2.57m0%
$ 0
Karin Walker
Chief Accounting Officer & Controller11.5yrsVeri yokVeri yok
Wagner Zago
Chief Scientific Officer7.4yrsUS$3.34mVeri yok
Mark Johnson
Vice President of Investor Relationsno dataVeri yokVeri yok
Michael Malecek
Chief Legal Officerno dataUS$1.18mVeri yok
David Ford
Chief People Officerless than a yearVeri yokVeri yok
Chad Swanson
Chief Development Officerless than a yearVeri yokVeri yok
Yvonne Tchrakian
Company Secretaryno dataVeri yokVeri yok

7.7yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: PRTA 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.7 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Gene Kinney
President8.2yrsUS$7.04m0.024%
$ 192.9k
Helen Kim
Independent Director2.3yrsUS$896.63k0%
$ 0
Richard Collier
Independent Director11.9yrsUS$912.48k0.0023%
$ 18.4k
Daniel Welch
Independent Chairmanless than a yearVeri yokVeri yok
Lars Ekman
Independent Chair Emeritusless than a yearUS$923.48k0.00045%
$ 3.7k
Shane Cooke
Independent Director11.9yrsUS$917.26k0%
$ 0
Dennis Selkoe
Independent Director11.3yrsUS$901.73k0.0078%
$ 63.5k
Paula Cobb
Independent Director5.3yrsUS$908.48k0%
$ 0
Oleg Nodelman
Independent Director4.9yrsVeri yokVeri yok
William Dunn
Independent Director1.5yrsUS$1.70mVeri yok

5.1yrs

Ortalama Görev Süresi

62yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: PRTA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.1 yıldır).